Search | La Lingua Nostra

added article Health

2026-04-22 13:43:03 -

Market Dynamics and Growth Factors in the Keytruda Industry

Pembrolizumab, the active compound in Keytruda, has become a cornerstone of precision oncology, enabling targeted cancer treatment through immune checkpoint inhibition. By blocking the PD-1 pathway, pembrolizumab enhances the body’s immune response against tumor cells, offering a more effective and less toxic alternative to conventional therapies. This innovation is a major factor driving...

0 Comments 0 Shares 73 Views 0 Reviews